Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Showing results (391-400 of 504) with videos related to

Pageof 51
Sort By:
Blood|December 18, 2012
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemiaDavide Rossi, Silvia Rasi, Valeria Spina, et al.
Leukemia & Lymphoma|April 11, 2015
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Laura Mosca, et al.
Blood Advances|May 10, 2022
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphomaAnastasios Stathis, Ulrich Mey, Sämi Schär, et al.
Blood|February 7, 2012
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemiaDavide Rossi, Marco Fangazio, Silvia Rasi, et al.
Blood|September 29, 2011
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairmentFortunato Morabito, Massimo Gentile, Carla Mazzone, et al.
Blood|September 3, 2010
Efficacy and safety of once-weekly bortezomib in multiple myeloma patientsSara Bringhen, Alessandra Larocca, Davide Rossi, et al.
Blood|September 2, 2011
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphomaDavide Rossi, Silvia Deaglio, David Dominguez-Sola, et al.
Blood|December 16, 2010
The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphomaDavide Rossi, Silvia Rasi, Alice Di Rocco, et al.
Blood|May 3, 2013
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemiaDavide Rossi, Valeria Spina, Riccardo Bomben, et al.
Cell|July 9, 2019
Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome PredictionDavid M Kurtz, Mohammad S Esfahani, Florian Scherer, et al.
Pageof 51

Showing results (391-400 of 504) with videos related to

Sort By:
Pageof 51
Blood|December 18, 2012
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemiaDavide Rossi, Silvia Rasi, Valeria Spina, et al.
Leukemia & Lymphoma|April 11, 2015
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Laura Mosca, et al.
Blood Advances|May 10, 2022
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphomaAnastasios Stathis, Ulrich Mey, Sämi Schär, et al.
Blood|February 7, 2012
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemiaDavide Rossi, Marco Fangazio, Silvia Rasi, et al.
Blood|September 29, 2011
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairmentFortunato Morabito, Massimo Gentile, Carla Mazzone, et al.
Blood|September 3, 2010
Efficacy and safety of once-weekly bortezomib in multiple myeloma patientsSara Bringhen, Alessandra Larocca, Davide Rossi, et al.
Blood|September 2, 2011
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphomaDavide Rossi, Silvia Deaglio, David Dominguez-Sola, et al.
Blood|December 16, 2010
The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphomaDavide Rossi, Silvia Rasi, Alice Di Rocco, et al.
Blood|May 3, 2013
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemiaDavide Rossi, Valeria Spina, Riccardo Bomben, et al.
Cell|July 9, 2019
Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome PredictionDavid M Kurtz, Mohammad S Esfahani, Florian Scherer, et al.
Pageof 51